Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

9.31
-0.1900-2.00%
Post-market: 9.21-0.1000-1.07%17:51 EDT
Volume:763.61K
Turnover:7.14M
Market Cap:791.95M
PE:-16.85
High:9.50
Open:9.40
Low:9.25
Close:9.50
Loading ...

Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment

Dow Jones
·
16 Jan

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
16 Jan

BRIEF-Anavex Life Sciences Announces Peer-Reviewed Publication Of Oral Blarcamesine Phase Iib/Iii Data In The Journal Of Prevention Of Alzheimer’S Disease

Reuters
·
15 Jan

Anavex announces peer-reviewed publication Phase IIb/III data on blarcamesine

TIPRANKS
·
15 Jan

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase Iib/Iii Data in the Journal of Prevention of Alzheimer’s Disease

THOMSON REUTERS
·
15 Jan

BRIEF-New Phase IIB/III Clinical Data Demonstrates Over Three Years Of Continuous Treatment With Oral Blarcamesine To Significantly Benefit Early Alzheimer’S Disease Patients

Reuters
·
13 Jan

New Phase Iib/Iii Clinical Data Demonstrates Over Three Years of Continuous Treatment With Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients

THOMSON REUTERS
·
13 Jan

Anavex Life Sciences Corp: Blarcamesine Exhibited a Favorable Safety Profile With No Treatment-Related Deaths

THOMSON REUTERS
·
13 Jan

Anavex Life Sciences Corp: Topline Attention-Ad Trial: Patients Showed Improved Cognition and Function Over Three Years

THOMSON REUTERS
·
13 Jan

Anavex Life Sciences (AVXL) Alzheimer Treatment Sends the Stock to New Heights

TIPRANKS
·
06 Jan

Are Medical Stocks Lagging Anavex Life Sciences (AVXL) This Year?

Zacks
·
31 Dec 2024

All You Need to Know About Anavex Life Sciences (AVXL) Rating Upgrade to Buy

Zacks
·
31 Dec 2024

Stock Track | Anavex Life Sciences Soars 5.25% in Pre-market as HC Wainwright Raises Price Target

Stock Track
·
27 Dec 2024

HC Wainwright Adjusts Price Target on Anavex Life Sciences to $42 From $40, Keeps Buy Rating

MT Newswires Live
·
27 Dec 2024

Stock Track | Anavex Life Sciences Soars 5.61% on Analyst Upgrade and Higher Price Target on Approval Prospects

Stock Track
·
26 Dec 2024

U.S. RESEARCH ROUNDUP-Apple, EverQuote, UnitedHealth

Reuters
·
26 Dec 2024

Anavex Life Sciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
26 Dec 2024

Anavex Life Sciences: Buy Rating Driven by European Approval Prospects and Strong Financial Position

TIPRANKS
·
26 Dec 2024

Anavex price target raised to $42 from $40 at H.C. Wainwright

TIPRANKS
·
26 Dec 2024

Anavex Life Sciences Corp. : H.c. Wainwright Raises Target Price to $42 From $40

THOMSON REUTERS
·
26 Dec 2024